Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDT-10013 in acute postoperative pain following TKA
NCT02263222Phase 2Withdrawn
- Sponsor
- Medtronic
- Start
- Feb 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MDT-10013 in acute postoperative pain, sponsored by Medtronic. Planned start Feb 2016; status: withdrawn.
02
Drugs
MDT-10013
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT02263222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02263222.